3.2M revenue from Covid POC + HIV in Q2.
We don’t know the split between the two.
If 50/50 then 1.6M Covid revenue in Q2.
And therefore at least 1.6M Covid revenue in Jan Q3.
Presuming this is stable, we would see 4.8M Covid revenue in Q3, representing 50% increase in total revenue from sales from Q2 to Q3.
Any revenue from HIV or a TGA approved Covid self test would be in addition.
Ann: Appendix 4C - 31 December 2021, page-12
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 497980 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 67200 | 3 |
View Market Depth
| Last trade - 15.47pm 02/08/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |
Day chart unavailable